Literature DB >> 8664113

Follow-up of bone lesions in an experimental multiple myeloma mouse model: description of an in vivo technique using radiography dedicated for mammography.

K Vanderkerken1, E Goes, H De Raeve, J Radl, B Van Camp.   

Abstract

The evolution of bone lesions in transplantable C57BL/KaLwRjj 5T mouse myeloma (MM) has been followed in vivo. Mice were anaesthetised and a radiograph of the pelvis and hind legs was performed by a radiograph dedicated for mammography. This is the first description of an in vivo technique under experimental conditions whereby the development of bone lesions owing to the MM growth was demonstrated.

Entities:  

Mesh:

Year:  1996        PMID: 8664113      PMCID: PMC2074558          DOI: 10.1038/bjc.1996.277

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  3 in total

1.  Animal model of human disease. Multiple myeloma.

Authors:  J Radl; J W Croese; C Zurcher; M H Van den Enden-Vieveen; A M de Leeuw
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

2.  Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.

Authors:  J Radl; E D De Glopper; H R Schuit; C Zurcher
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

3.  Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma.

Authors:  J Radl; J W Croese; C Zurcher; M H van den Enden-Vieveen; R J Brondijk; M Kazil; J J Haaijman; P H Reitsma; O L Bijvoet
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

  3 in total
  11 in total

1.  Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.

Authors:  Sonia D'Souza; Davide del Prete; Shunqian Jin; Quanhong Sun; Alissa J Huston; Flavia Esteve Kostov; Benedicte Sammut; Chang-Sook Hong; Judith L Anderson; Kenneth D Patrene; Shibing Yu; Chinavenmeni S Velu; Guozhi Xiao; H Leighton Grimes; G David Roodman; Deborah L Galson
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

2.  Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.

Authors:  Els Van Valckenborgh; Peter I Croucher; Hendrik De Raeve; Chris Carron; Evy De Leenheer; Sylvia Blacher; Laetitia Devy; Agnès Noël; Elke De Bruyne; Kewal Asosingh; Ivan Van Riet; Ben Van Camp; Karin Vanderkerken
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

3.  Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.

Authors:  Babatunde O Oyajobi; Steve Muñoz; Rami Kakonen; Paul J Williams; Anjana Gupta; Christi L Wideman; Beryl Story; Barry Grubbs; Allison Armstrong; William C Dougall; I Ross Garrett; Gregory R Mundy
Journal:  Mol Cancer Ther       Date:  2007-05-31       Impact factor: 6.261

4.  Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.

Authors:  K Vanderkerken; H De Raeve; E Goes; S Van Meirvenne; J Radl; I Van Riet; K Thielemans; B Van Camp
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo.

Authors:  E Van Valckenborgh; H De Raeve; L Devy; S Blacher; C Munaut; A Noël; E Van Marck; I Van Riet; B Van Camp; K Vanderkerken
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

6.  Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor.

Authors:  I Vande Broek; K Vanderkerken; C De Greef; K Asosingh; N Straetmans; B Van Camp; I Van Riet
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

7.  Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse.

Authors:  K Vanderkerken; C De Greef; K Asosingh; B Arteta; M De Veerman; I Vande Broek; I Van Riet; M Kobayashi; B Smedsrod; B Van Camp
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

Review 8.  Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.

Authors:  Michael Pisano; Yan Cheng; Fumou Sun; Binod Dhakal; Anita D'Souza; Saurabh Chhabra; Jennifer M Knight; Sridhar Rao; Fenghuang Zhan; Parameswaran Hari; Siegfried Janz
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

9.  A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease.

Authors:  Peter O Hofgaard; Henriette C Jodal; Kurt Bommert; Bertrand Huard; Jo Caers; Harald Carlsen; Rolf Schwarzer; Nicole Schünemann; Franziska Jundt; Mona M Lindeberg; Bjarne Bogen
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease.

Authors:  Michelle A Lawson; Julia M Paton-Hough; Holly R Evans; Rebecca E Walker; William Harris; Dharshi Ratnabalan; John A Snowden; Andrew D Chantry
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.